Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04495790 · ClinicalTrials.gov registry record

AIMS Cancer Outcomes Study

A clinical trial of Advanced Solid Tumor and Neoplasms, sponsored by Advanced Integrative Medical Science Institute.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT04495790 is a study of Advanced Solid Tumor and Neoplasms that is actively recruiting participants, run by Advanced Integrative Medical Science Institute. The registered enrollment target is 500 participants, above the 190-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (163% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04495790, a study of Advanced Solid Tumor and Neoplasms, is actively recruiting participants, sponsored by Advanced Integrative Medical Science Institute.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.

Study Locations (1)

Washington

  • AIMS Institute - Seattle

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2020-05-18
Est. Completion 2030-12-31

What the Registry Record Tells You About NCT04495790

The ClinicalTrials.gov registry entry for NCT04495790 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 190-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (163% higher). The listed sponsor is Advanced Integrative Medical Science Institute, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Advanced Solid Tumor appearing as the primary indexed condition, and to 0 interventions.

NCT04495790 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04495790 about?

NCT04495790 is a clinical study titled "AIMS Cancer Outcomes Study". The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect d...

What is the current status of trial NCT04495790?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-05-18. Estimated completion is 2030-12-31.

What conditions does trial NCT04495790 study?

This clinical trial studies the following conditions: Advanced Solid Tumor, Neoplasms, Advanced Cancer, Oncology, Neoplasm Malignant.

Who is sponsoring clinical trial NCT04495790?

This trial is sponsored by Advanced Integrative Medical Science Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04495790 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.